AMGEN INC 10-K filing
Filed 2026-02-13 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0000318154-26-000010
- Form type
- 10-K
- CIK
- 0000318154
- Primary document
- https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/amgn-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AMGEN INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $36.8B | - | - |
| Cost Of Revenue | $12.0B | - | - |
| Operating Income | $9.1B | - | - |
| Net Income | $7.7B | - | - |
| Eps Basic | 14.33 | - | - |
| Eps Diluted | 14.23 | - | - |
| Cash And Equivalents | $9.1B | - | - |
| Total Assets | $90.6B | - | - |
| Shareholders Equity | $8.7B | - | - |
| Operating Cash Flow | $10.0B | - | - |
| Capital Expenditures | $1.9B | - | - |